4
Changes in Ownership
BlossomHill Therapeutics, Inc. Filed Acc 0002144320-26-000003
Options or other derivatives
- Chief Medical Officer acquired 61,783 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Oxnard Geoffrey Raymond Chief Medical Officer | 2026-08-06 | Grant or award · Employee Stock Option (Right to Buy) | +61,783 | 61,783 | D | ||
Loading xslF345X06/form4-08102026_100847.xml…